Advertisement

Head and Neck Neuroendocrine Tumors

  • Edward B. Stelow
Chapter
Part of the Molecular Pathology Library book series (MPLB, volume 3)

Abstract

The head and neck region contains a number of disparate organs ranging from skin to brain, and many of the neuroendocrine tumors of these organs have been discussed elsewhere in this book (skin, thyroid, and pituitary gland). Extra-adrenal paragangliomas, although also discussed elsewhere, will be mentioned and discussed briefly as they pertain to the ear and upper aerodigestive tract. This chapter will concentrate on neuroendocrine tumors of the ear, upper aerodigestive tract, and salivary glands. Focusing on these entities leaves only a few head- and neck-specific tumors to discuss, including middle ear adenoma, neuroendocrine carcinomas of the upper aerodigestive tract and salivary glands, uncommon and unique neuroectodermal tumors of the area, and, as mentioned, paraganglioma. Even if taken together, these tumors are exceedingly rare and little is known regarding the genetics of the tumors. While this limits our discussion, it does leave open some exciting avenues of possible research.

Keywords

Carcinoid Tumor Small Cell Carcinoma Pleomorphic Adenoma Neuroendocrine Carcinoma Merkel Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Batsakis JG, el-Naggar AK, Luna MA. Neuroendocrine tumors of larynx. Ann Otol Rhinol Laryngol. 1992;101:710–714.PubMedGoogle Scholar
  2. 2.
    Ferlito A, Barnes L, Rinaldo A, Gnepp DR, Milroy CM. A review of neuroendocrine neoplasms of the larynx: update on diagnosis and treatment. J Laryngol Otol. 1998;112:827–834.PubMedGoogle Scholar
  3. 3.
    Ferlito A, Friedmann I. Review of neuroendocrine carcinomas of the larynx. Ann Otol Rhinol Laryngol. 1989;98:780–790.PubMedGoogle Scholar
  4. 4.
    Gnepp DR, Ferlito A, Hyams V. Primary anaplastic small cell (oat cell) carcinoma of the larynx. Review of the literature and report of 18 cases. Cancer. 1983;51:1731–1745.CrossRefPubMedGoogle Scholar
  5. 5.
    Logue JP, Banerjee SS, Slevin NJ, Vasanthan S. Neuroendocrine carcinomas of the larynx. J Laryngol Otol. 1991;105:1031–1035.CrossRefPubMedGoogle Scholar
  6. 6.
    Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol. 2002;15:264–278.CrossRefPubMedGoogle Scholar
  7. 7.
    Perez-Ordonez B, Caruana SM, Huvos AG, Shah JP. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. Hum Pathol. 1998;29:826–832.CrossRefPubMedGoogle Scholar
  8. 8.
    Ferlito A, Devaney KO, Rinaldo A. Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management. Oral Oncol. 2006;42:770–788.CrossRefPubMedGoogle Scholar
  9. 9.
    Gillenwater A, Lewin J, Roberts D, El-Naggar A. Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the larynx: a clinically aggressive tumor. Laryngoscope. 2005;115:1191–1195.CrossRefPubMedGoogle Scholar
  10. 10.
    Argani P, Perez-Ordonez B, Xiao H, Caruana SM, Huvos AG, Ladanyi M. Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression. Am J Surg Pathol. 1998;22:391–398.CrossRefPubMedGoogle Scholar
  11. 11.
    Mills SE, Cooper PH, Garland TA, Johns ME. Small cell undifferentiated carcinoma of the larynx. Report of two patients and review of 13 additional cases. Cancer. 1983;51:116–120.CrossRefPubMedGoogle Scholar
  12. 12.
    Woodruff JM, Huvos AG, Erlandson RA, Shah JP, Gerold FP. Neuroendocrine carcinomas of the larynx. A study of two types, one of which mimics thyroid medullary carcinoma. Am J Surg Pathol. 1985;9:771–790.CrossRefPubMedGoogle Scholar
  13. 13.
    Chung JH, Lee SS, Shim YS, et al. A study of moderately differentiated neuroendocrine carcinomas of the larynx and an examination of non-neoplastic larynx tissue for neuroendocrine cells. Laryngoscope. 2004;114:1264–1270.CrossRefPubMedGoogle Scholar
  14. 14.
    Hirsch MS, Faquin WC, Krane JF. Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid. Mod Pathol. 2004;17:631–636.CrossRefPubMedGoogle Scholar
  15. 15.
    Ejaz A, Wenig BM. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis. Adv Anat Pathol. 2005;12:134–143.CrossRefPubMedGoogle Scholar
  16. 16.
    Enepekides DJ. Sinonasal undifferentiated carcinoma: an update. Curr Opin Otolaryngol Head Neck Surg. 2005;13:222–225.CrossRefPubMedGoogle Scholar
  17. 17.
    Frierson HF Jr, Mills SE, Fechner RE, Taxy JB, Levine PA. Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol. 1986;10:771–779.CrossRefPubMedGoogle Scholar
  18. 18.
    Bourne TD, Bellizzi AM, Stelow EB, et al. p63 expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract. Am J Clin Pathol. 2008;130(2):213–218.CrossRefPubMedGoogle Scholar
  19. 19.
    Gil Z, Orr-Urtreger A, Voskoboinik N, et al. Cytogenetic analysis of sinonasal carcinomas. Otolaryngol Head Neck Surg. 2006;134:654–660.CrossRefPubMedGoogle Scholar
  20. 20.
    Bellizzi AM, Bourne TD, Mills SE, Stelow EB. Immunohistochemistry of molecular markers in sinonasal undifferentiated carcinomas. Mod Pathol. 2007;20:220A.CrossRefGoogle Scholar
  21. 21.
    Joos B, Martin A, Nowacki M, Desai P, Jenson A, Farghaly H. Prevalence of human papilloma virus DNA in sinonasal undifferentiated carcinoma. Mod Pathol. 2008;21:237A.Google Scholar
  22. 22.
    Chernock RD, Perry A, Pfeifer J, Holden JA, Lewis JS. Evaluation of sinonasal undifferentiated carcinomas for therapeutic targets - EGFR, c-kit and Her2/neu. Mod Pathol. 2008;21:233A.Google Scholar
  23. 23.
    Barnes L. Paraganglioma of the larynx. A critical review of the literature. ORL J Otorhinolaryngol Relat Spec. 1991;53:220–234.PubMedGoogle Scholar
  24. 24.
    Lack EE, Cubilla AL, Woodruff JM. Paragangliomas of the head and neck region. A pathologic study of tumors from 71 patients. Hum Pathol. 1979;10:191–218.CrossRefPubMedGoogle Scholar
  25. 25.
    Lack EE, Cubilla AL, Woodruff JM, Farr HW. Paragangliomas of the head and neck region: a clinical study of 69 patients. Cancer. 1977;39:397–409.CrossRefPubMedGoogle Scholar
  26. 26.
    Pellitteri PK, Rinaldo A, Myssiorek D, et al. Paragangliomas of the head and neck. Oral Oncol. 2004;40:563–575.CrossRefPubMedGoogle Scholar
  27. 27.
    Barrett AW, Morgan M, Ramsay AD, Farthing PM, Newman L, Speight PM. A clinicopathologic and immunohistochemical analysis of melanotic neuroectodermal tumor of infancy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:688–698.CrossRefPubMedGoogle Scholar
  28. 28.
    Kapadia SB, Frisman DM, Hitchcock CL, Ellis GL, Popek EJ. Melanotic neuroectodermal tumor of infancy. Clinicopathological, immunohistochemical, and flow cytometric study. Am J Surg Pathol. 1993;17:566–573.CrossRefPubMedGoogle Scholar
  29. 29.
    Kruse-Losler B, Gaertner C, Burger H, Seper L, Joos U, Kleinheinz J. Melanotic neuroectodermal tumor of infancy: systematic review of the literature and presentation of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:204–216.CrossRefPubMedGoogle Scholar
  30. 30.
    Pettinato G, Manivel JC, D’Amore ES, Jaszcz W, Gorlin RJ. Melanotic neuroectodermal tumor of infancy. A reexamination of a histogenetic problem based on immunohistochemical, flow cytometric, and ultrastructural study of 10 cases. Am J Surg Pathol. 1991;15:233–245.CrossRefPubMedGoogle Scholar
  31. 31.
    Stirling RW, Powell G, Fletcher CD. Pigmented neuroectodermal tumour of infancy: an immunohistochemical study. Histopathology. 1988;12:425–435.CrossRefPubMedGoogle Scholar
  32. 32.
    Metwaly H, Cheng J, Maruyama S, et al. Establishment and characterization of new cell lines derived from melanotic neuroectodermal tumor of infancy arising in the mandible. Pathol Int. 2005;55:331–342.CrossRefPubMedGoogle Scholar
  33. 33.
    Frierson HF Jr, Ross GW, Mills SE, Frankfurter A. Olfactory neuroblastoma. Additional immunohistochemical characterization. Am J Clin Pathol. 1990;94:547–553.PubMedGoogle Scholar
  34. 34.
    Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer. 1976;37:1571–1576.CrossRefPubMedGoogle Scholar
  35. 35.
    Mills SE, Frierson HF Jr. Olfactory neuroblastoma. A clinicopathologic study of 21 cases. Am J Surg Pathol. 1985;9:317–327.CrossRefPubMedGoogle Scholar
  36. 36.
    Loy AH, Reibel JF, Read PW, et al. Esthesioneuroblastoma: continued follow-up of a single institution’s experience. Arch Otolaryngol Head Neck Surg. 2006;132:134–138.CrossRefPubMedGoogle Scholar
  37. 37.
    Mills SE, Gaffey MJ, Frierson HF. Neural, Neuroendocrine, and Neuroectodermal Neoplasia. Tumors of the Upper Aerodigestive Tract and Ear, vol. 26. 3rd ed. Washington, DC: AFIP; 2000:159.Google Scholar
  38. 38.
    Hirose T, Scheithauer BW, Lopes MB, et al. Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer. 1995;76:4–19.CrossRefPubMedGoogle Scholar
  39. 39.
    Kumar S, Perlman E, Pack S, et al. Absence of EWS/FLI1 fusion in olfactory neuroblastomas indicates these tumors do not belong to the Ewing’s sarcoma family. Hum Pathol. 1999;30:1356–1360.CrossRefPubMedGoogle Scholar
  40. 40.
    Sorensen PH, Wu JK, Berean KW, et al. Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma. Proc Natl Acad Sci U S A. 1996;93:1038–1043.CrossRefPubMedGoogle Scholar
  41. 41.
    Guled M, Myllykangas S, Frierson HF Jr, Mills SE, Knuutila S, Stelow EB. Array comparative genomic hybridization analysis of olfactory neuroblastoma. Mod Pathol. 2008;21:770–778.CrossRefPubMedGoogle Scholar
  42. 42.
    Wang SL, Chen WT, Li SH, Li SW, Yang SF, Chai CY. Expression of human telomerase reverse transcriptase and cyclin-D1 in olfactory neuroblastoma. APMIS. 2007;115:17–21.CrossRefPubMedGoogle Scholar
  43. 43.
    Diensthuber M, Potinius M, Rodt T, et al. Expression of bcl-2 is associated with microvessel density in olfactory neuroblastoma. J Neurooncol. 2008;89(2):131–139.CrossRefPubMedGoogle Scholar
  44. 44.
    Gnepp DR, Corio RL, Brannon RB. Small cell carcinoma of the major salivary glands. Cancer. 1986;58:705–714.CrossRefPubMedGoogle Scholar
  45. 45.
    Koss LG, Spiro RH, Hajdu S. Small cell (oat cell) carcinoma of minor salivary gland origin. Cancer. 1972;30:737–741.CrossRefPubMedGoogle Scholar
  46. 46.
    Kraemer BB, Mackay B, Batsakis JG. Small cell carcinomas of the parotid gland. A clinicopathologic study of three cases. Cancer. 1983;52:2115–2121.CrossRefPubMedGoogle Scholar
  47. 47.
    Nagao K, Matsuzaki O, Saiga H, et al. Histopathologic studies of undifferentiated carcinoma of the parotid gland. Cancer. 1982;50:1572–1579.CrossRefPubMedGoogle Scholar
  48. 48.
    Nagao T, Gaffey TA, Olsen KD, Serizawa H, Lewis JE. Small cell carcinoma of the major salivary glands: clinicopathologic study with emphasis on cytokeratin 20 immunoreactivity and clinical outcome. Am J Surg Pathol. 2004;28:762–770.CrossRefPubMedGoogle Scholar
  49. 49.
    Michaels L, Lee K, Manuja SL, Soucek SO. Family with low-grade neuroendocrine carcinoma of salivary glands, severe sensorineural hearing loss, and enamel hypoplasia. Am J Med Genet. 1999;83:183–186.CrossRefPubMedGoogle Scholar
  50. 50.
    Modlin IM, Shapiro MD, Kidd M. Primary carcinoid tumor of the parotid gland: a case report and review of the literature. Ear Nose Throat J. 2006;85:533–539.PubMedGoogle Scholar
  51. 51.
    Laforga JB. Salivary duct carcinoma with neuroendocrine features. Virchows Arch. 2004;444:473–476.CrossRefPubMedGoogle Scholar
  52. 52.
    Gnepp DR, Wick MR. Small cell carcinoma of the major salivary glands. An immunohistochemical study. Cancer. 1990;66:185–192.CrossRefPubMedGoogle Scholar
  53. 53.
    Berns S, Pearl G. Middle ear adenoma. Arch Pathol Lab Med. 2006;130:1067–1069.PubMedGoogle Scholar
  54. 54.
    Krouse JH, Nadol JB Jr, Goodman ML. Carcinoid tumors of the middle ear. Ann Otol Rhinol Laryngol. 1990;99:547–552.PubMedGoogle Scholar
  55. 55.
    Manni JJ, Faverly DR, Van Haelst UJ. Primary carcinoid tumors of the middle ear. Report on four cases and a review of the literature. Arch Otolaryngol Head Neck Surg. 1992;118:1341–1347.PubMedGoogle Scholar
  56. 56.
    Michaels L, Soucek S. Adenoma of the middle ear. In: Bachor E, Eveson JW, Reichart P, Sidransky D, eds. Pathology and Genetics of Head and Neck Tumors. Lyon: IARC Press; 2005:345.Google Scholar
  57. 57.
    Mills SE, Fechner RE. Middle ear adenoma. A cytologically uniform neoplasm displaying a variety of architectural patterns. Am J Surg Pathol. 1984;8:677–685.CrossRefPubMedGoogle Scholar
  58. 58.
    Ramsey MJ, Nadol JB Jr, Pilch BZ, McKenna MJ. Carcinoid tumor of the middle ear: clinical features, recurrences, and metastases. Laryngoscope. 2005;115:1660–1666.CrossRefPubMedGoogle Scholar
  59. 59.
    Stanley MW, Horwitz CA, Levinson RM, Sibley RK. Carcinoid tumors of the middle ear. Am J Clin Pathol. 1987;87:592–600.PubMedGoogle Scholar
  60. 60.
    Torske KR, Thompson LD. Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature. Mod Pathol. 2002;15:543–555.CrossRefPubMedGoogle Scholar
  61. 61.
    Wassef M, Kanavaros P, Polivka M, et al. Middle ear adenoma. A tumor displaying mucinous and neuroendocrine differentiation. Am J Surg Pathol. 1989;13:838–847.CrossRefPubMedGoogle Scholar
  62. 62.
    Hyams VJ, Batsakis JG, Michaels L. Neoplasms of the Middle Ear. Tumors of the Upper Respiratory Tract and Ear. Washington, DC: Armed Forces Institute of Pathology; 1988:306–330.Google Scholar
  63. 63.
    Achilles E, Padberg BC, Holl K, Kloppel G, Schroder S. Immunocytochemistry of paragangliomas - value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis. Histopathology. 1991;18:453–458.CrossRefPubMedGoogle Scholar
  64. 64.
    Brown JS. Glomus jugulare tumors revisited: a ten-year statistical follow-up of 231 cases. Laryngoscope. 1985;95:284–288.CrossRefPubMedGoogle Scholar
  65. 65.
    Alford BR, Guilford FR. A comprehensive study of tumors of the glomus jugulare. Laryngoscope. 1962;72:765–805.CrossRefPubMedGoogle Scholar
  66. 66.
    Spector GJ, Maisel RH, Ogura JH. Glomus tumors in the middle ear. I. An analysis of 46 patients. Laryngoscope. 1973;83:1652–1672.CrossRefPubMedGoogle Scholar
  67. 67.
    Bikhazi PH, Messina L, Mhatre AN, Goldstein JA, Lalwani AK. Molecular pathogenesis in sporadic head and neck paraganglioma. Laryngoscope. 2000;110:1346–1348.CrossRefPubMedGoogle Scholar
  68. 68.
    Isik AC, Erem C, Imamoglu M, Cinel A, Sari A, Maral G. Familial paraganglioma. Eur Arch Otorhinolaryngol. 2006;263:23–31.CrossRefPubMedGoogle Scholar
  69. 69.
    Martin TP, Irving RM, Maher ER. The genetics of paragangliomas: a review. Clin Otolaryngol. 2007;32:7–11.CrossRefPubMedGoogle Scholar
  70. 70.
    Neumann HP, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. 2004;292:943–951.CrossRefPubMedGoogle Scholar
  71. 71.
    Schiavi F, Boedeker CC, Bausch B, et al. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA. 2005;294:2057–2063.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Edward B. Stelow
    • 1
  1. 1.Department of PathologyUniversity of VirginiaCharlottesvilleUSA

Personalised recommendations